**4/4/2022: Updated to include new vaccine booster information. See red text below for update.** Actions Requested Be aware, the Centers for Disease Control and Prevention (CDC) and Western States Scientific Safety Review Workgroup have endorsed the Food and Drug Administration (FDA) emergency use authorization of a second booster dose of either the Pfizer-BioNTech (Pfizer) or … Health Advisory: COVID-19 Updates for Providers
Click here to access the latest Kitsap Respiratory Illness Report: 3.13.22 – 3.19.22
Click here to access the latest Kitsap Respiratory Illness Report: 3.6.22 – 3.12.22
Click here to access the latest Kitsap Respiratory Illness Report: 2.27.22 – 3.5.22
Actions Requested Be aware, on March 4, the WA Dept. of Health (DOH) discontinued ordering of the Johnson & Johnson (Janssen) COVID-19 vaccine due to extremely limited inventory at the Centers for Disease Control and Prevention (CDC) in the Washington Immunization Information System (IIS). Providers are encouraged to post and look for excess doses in … Health Advisory: COVID-19 Updates for Providers
Click here to access the latest Kitsap Respiratory Illness Report: 2.20.22 – 2.26.22
Actions Requested Be aware, on Feb. 22, Centers for Disease Control and Prevention (CDC) revised its COVID-19 vaccine clinical considerations. An 8-week interval between first and second doses of mRNA COVID-19 vaccine (Moderna and Pfizer) may be optimal for males 12–39 years old to reduce risk of myocarditis and increase efficacy. CDC still recommends a … Health Advisory: COVID-19 Updates for Providers
Click here to access the latest Kitsap Respiratory Illness Report: 2.13.22 – 2.19-22
Click here to access the latest Kitsap Respiratory Illness Report: 2.6.22 – 2.12.22.
Actions Requested Be aware, on February 11, the Centers for Disease Control and Prevention updated their guidance for COVID-19 vaccination to include: People who are moderately or severely immunocompromised should: Complete their primary series of 2 mRNA (Pfizer-BioNTech or Moderna) doses, a third dose at least 28 days after the initial two-dose series and an mRNA … Health Advisory: COVID-19 Updates for Providers
